{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:37:02Z","timestamp":1783820222346,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ID No. 5\/3\/3\/4\/2013-ECD-I dated 13.3.15"],"award-info":[{"award-number":["ID No. 5\/3\/3\/4\/2013-ECD-I dated 13.3.15"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193678","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T18:29:02Z","timestamp":1520360942000},"page":"e0193678","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2737-8102","authenticated-orcid":true,"given":"Vikram","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-8272","authenticated-orcid":true,"given":"Manju","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-3302","authenticated-orcid":true,"given":"Aradhana","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"e1002366","DOI":"10.1371\/journal.pmed.1002366","article-title":"Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines","volume":"14","author":"E Alirol","year":"2017","journal-title":"PLoS Med"},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention. Centers for disease control and prevention: STD Surveillance 2016. Division of STD Prevention, U.S Department of Health and Human Services, Atlanta, Georgia. 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/std\/stats16\/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/std\/stats16\/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/OLQ.0b013e31822e6361","article-title":"Characterization of profile of multi drug-resistant <italic>Neisseria gonorrhoeae<\/italic> using old and new definitions in India over a decade: 2000\u20132009","volume":"38","author":"M Bala","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant <italic>Neisseria gonorrhoeae<\/italic> in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"M Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","article-title":"Monitoring antimicrobial resistance in <italic>Neisseria gonorrhoeae<\/italic> in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis","volume":"89","author":"M Bala","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"3","key":"ref6","first-page":"587","article-title":"Antimicrobial resistance in <italic>Neisseria gonorrhoeae<\/italic> in the 21st century: past, evolution, and future","volume":"27","author":"M Unemo","year":"2014","journal-title":"ClinMicrobiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving <italic>Neisseria gonorrhoeae<\/italic> continues to challenge","volume":"15","author":"M Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/OLQ.0000000000000261","article-title":"Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002\u20132006 and 2007\u20132012","volume":"42","author":"M Bala","year":"2015","journal-title":"Sex Transm Dis"},{"key":"ref9","unstructured":"National AIDS Control Organisation. National guidelines on prevention, management and control of reproductive tract infections and sexually transmitted infections. Department of AIDS control, STI\/RTI Division. 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicalestablishments.nic.in\/WriteReadData\/448.pdf\" xlink:type=\"simple\">http:\/\/clinicalestablishments.nic.in\/WriteReadData\/448.pdf<\/ext-link>."},{"key":"ref10","first-page":"1","article-title":"WHO guidelines for the treatment of <italic>Neisseria gonorrhoeae<\/italic>","year":"2016"},{"key":"ref11","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"KA Workowski","year":"2015","journal-title":"Centers for Disease Control and Prevention. MMWR Recomm Rep"},{"issue":"25","key":"ref12","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"H Fifer","year":"2016","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.02093-13","article-title":"First three <italic>Neisseria gonorrhoeae<\/italic> isolates with high-level resistance to azithromycin in Sweden-threat to currently available dual antimicrobial regimens for treatment of gonorrhea?","volume":"58","author":"M Unemo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","article-title":"Global action plan to control the spread and impact of antimicrobial resistance in <italic>Neisseria gonorrhoea<\/italic>","year":"2012"},{"key":"ref15","article-title":"In vitro synergy testing of gentamicin, an old drug suggested as future treatment option for gonorrhoea, in combination with six other antimicrobials against multidrug-resistant <italic>Neisseria gonorrhoeae<\/italic> strains","author":"V Singh","year":"2017","journal-title":"Sex Trans Dis"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s10156-013-0597-6","article-title":"In vitro activities of antimicrobial combinations against clinical isolates of <italic>Neisseria gonorrhoeae<\/italic>","volume":"19","author":"R Furuya","year":"2013","journal-title":"J Infect Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jac\/dks449","article-title":"Combination therapy for gonorrhoea: in vitro synergy testing","volume":"68","author":"R Pereira","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/jac\/dkt540","article-title":"In vitro synergy testing of novel antimicrobial combination therapies against <italic>Neisseria gonorrhoeae<\/italic>","volume":"69","author":"LA Barbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1128\/AAC.01907-16","article-title":"Gentamicin susceptibility among a sample of multidrug-resistant <italic>Neisseria gonorrhoeae<\/italic> isolates in India","volume":"60","author":"M Bala","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e000969","DOI":"10.1136\/bmjopen-2012-000969","article-title":"Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of <italic>Neisseria gonorrhoeae<\/italic>: a 6-year study","volume":"2","author":"V Singh","year":"2012","journal-title":"BMJ Open"},{"key":"ref21","first-page":"P56","article-title":"Antibiotic susceptibility testing by the CDS method. A manual for medical and veterinary laboratories","author":"SM Bell","year":"2016"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jac\/dkw102","article-title":"Gentamicin in vitro activity and tentative gentamicin interpretation criteria for the CLSI and calibrated dichotomous sensitivity disc diffusion methods for <italic>Neisseria gonorrhoeae<\/italic>","volume":"71","author":"M Bala","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref23","unstructured":"AB Biodisk. Etest application sheet. M0000503-MH0184 AB Biodisk, Solna, Sweden. 2007. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ilexmedical.com\/files\/EtestApplicationSheets\/combinationtesting.pdf\" xlink:type=\"simple\">http:\/\/www.ilexmedical.com\/files\/EtestApplicationSheets\/combinationtesting.pdf<\/ext-link>."},{"key":"ref24","first-page":"1238","article-title":"Antibiotics in Laboratory Medicine","volume":"xvi","author":"V Lorian","year":"1996"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10156-006-0445-Z","article-title":"In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of <italic>Neisseria gonorrhoeae<\/italic>","volume":"12","author":"R Furuya","year":"2006","journal-title":"J infect chemother"},{"issue":"Suppl 1","key":"ref26","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1136\/sextrans-2013-051184.0351","article-title":"In vitro antimicrobial synergy testing, using Etest methodology, of <italic>Neisseria gonorrhoeae<\/italic> for evaluation of susceptibility when using dual antimicrobial therapy?","volume":"Vol. 89","author":"D Golparian","year":"2013","journal-title":"Sexually Transmitted Infections"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijantimicag.2014.10.020","article-title":"Determination of in vitro synergy for dual antimicrobial therapy against resistant <italic>Neisseria gonorrhoeae<\/italic> using Etest and agar dilution","volume":"45","author":"CM Wind","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.diagmicrobio.2016.10.022","article-title":"In vitro activity of tigecycline alone and antimicrobial combinations against clinical <italic>Neisseria gonorrhoeae<\/italic> isolates","volume":"87","author":"H Lee","year":"2017","journal-title":"DiagnMicrobiol Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"<italic>Neisseria gonorrhoeae<\/italic> antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"LB Brown","year":"2010","journal-title":"Sex Transm Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"RD Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/AAC.00326-12","article-title":"In vitro activity of ertapenem versus ceftriaxone against <italic>Neisseria gonorrhoeae<\/italic> isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: Ertapenem for treatment of gonorrhea?","volume":"56","author":"M Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T12:30:30Z","timestamp":1660566630000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193678"}},"subtitle":[],"editor":[{"given":"William M","family":"Shafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193678","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}